Contact Us
1 min read

Podcast | Boosting Patient Adherence: The Power of Clinical Support Programs

UBC talked to Pharmaceutical Commerce about the important role clinical adherence programs play for patients on complex therapies.
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.

AI is here – are you ready?

Amanda Scholz, MHA, BSN, RN, and Senior Clinical Program Manager at UBC, sat down with Pharmaceutical Commerce recently to discuss the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey. Find out how AI can benefit patients, prescribers, and brands with the full podcast below.

About UBC’s Patient Access Solutions

UBC’s patient access solutions are designed to create the optimal patient experience, guiding them through access hurdles and facilitating long-term adherence to medication. With a personalized approach enabled by technology, we eliminate barriers and accelerate speed to therapy. Get in touch with us here.

Other Recent Posts

View More
Above view of group of business persons in business meeting. Group of entrepreneurs on meeting in board room. Corporate business team on meeting in the office.
Press
August 11, 20254 min read

UBC Launches New Pharmacovigilance Reporting Capabilities

UBC launches new RxLogix pharmacovigilance reporting platform to enhance drug safety capabilities with advanced aggregate reporting, real-time analytics, and reduced regulatory risk for biopharmaceutical companies.
Two diverse professionals, a man and a woman, collaborate intently on a computer screen in a dimly lit office. The man points at the monitor while the woman observes.
Press
April 24, 20254 min read

UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025

UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix®, and a major contender in the Post-approval category. The recognition highlights UBC’s strength in delivering innovative, compliant, and patient-focused PV solutions across the drug development lifecycle.
The Osmind logo features the company name in a gradient color scheme, transitioning from purple on the left to orange on the right, set against a white background.
Press
October 29, 20245 min read

UBC Announces Partnership with Osmind to Advance the Future of Mental Health Treatment and Research within REMS

First-of-its-kind partnership in mental health care reduces REMS implementation burden, improves the quality of REMS data, and optimizes safe medication use and health outcomes

Want to know more about us?

Subscribe Now

Want to know more about us?

Subscribe Now

About us

Solutions

Insights

Resources

For HCPs

Clinical

Contact us

About UBC

Other

Evidence Development

Safety & Risk Management

Patient Access

Providers

Technology Solutions

The logo for UBC, which features a teal stylized swirling design on the left, followed by "UBC" in the same teal color.
©2025 United BioSource LLC, all rights reserved
UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC.
Twitter Linkedin
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.